CLBT – Cellebrite DI Ltd.
CLBT — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
4.09
Margin Of Safety %
-9
Put/Call OI Ratio
0.21
EPS Next Q Diff
0.03
EPS Last/This Y
0.21
EPS This/Next Y
0.08
Price
14.15
Target Price
21.67
Analyst Recom
1
Performance Q
-21.65
Upside
-23.3%
Beta
1.3
Ticker: CLBT
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | CLBT | 14.93 | 0.22 | 0.33 | 34220 |
| 2026-03-10 | CLBT | 14.73 | 0.22 | 1.03 | 34137 |
| 2026-03-11 | CLBT | 14.47 | 0.22 | 0.35 | 33998 |
| 2026-03-12 | CLBT | 14.55 | 0.22 | 0.83 | 33986 |
| 2026-03-13 | CLBT | 14.53 | 0.22 | 0.83 | 33986 |
| 2026-03-17 | CLBT | 14.7 | 0.22 | 0.44 | 34052 |
| 2026-03-18 | CLBT | 14.58 | 0.22 | 1.09 | 34094 |
| 2026-03-19 | CLBT | 14.86 | 0.22 | 2.00 | 34089 |
| 2026-03-20 | CLBT | 14.28 | 0.22 | 0.12 | 34074 |
| 2026-03-23 | CLBT | 14.83 | 0.20 | 0.83 | 29533 |
| 2026-03-24 | CLBT | 14.21 | 0.20 | 0.16 | 29984 |
| 2026-03-25 | CLBT | 14.16 | 0.20 | 0.92 | 30106 |
| 2026-03-26 | CLBT | 13.78 | 0.21 | 0.20 | 30155 |
| 2026-03-27 | CLBT | 12.95 | 0.21 | 0.87 | 30195 |
| 2026-03-30 | CLBT | 13.23 | 0.21 | 1.06 | 30189 |
| 2026-03-31 | CLBT | 13.79 | 0.22 | 0.58 | 30842 |
| 2026-04-01 | CLBT | 13.89 | 0.22 | 0.70 | 30911 |
| 2026-04-02 | CLBT | 14 | 0.22 | 0.74 | 30906 |
| 2026-04-06 | CLBT | 14.1 | 0.22 | 1.26 | 30907 |
| 2026-04-07 | CLBT | 14.15 | 0.21 | 0.53 | 30686 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | CLBT | 14.93 | -0.4 | - | 0.55 |
| 2026-03-10 | CLBT | 14.73 | -5.4 | - | 0.53 |
| 2026-03-11 | CLBT | 14.48 | -5.4 | - | 0.53 |
| 2026-03-12 | CLBT | 14.55 | -5.4 | - | 0.53 |
| 2026-03-13 | CLBT | 14.45 | -5.4 | - | 0.53 |
| 2026-03-17 | CLBT | 14.69 | -5.4 | - | 0.53 |
| 2026-03-18 | CLBT | 14.58 | -5.4 | - | 0.53 |
| 2026-03-19 | CLBT | 14.86 | -5.4 | - | 0.53 |
| 2026-03-20 | CLBT | 14.27 | -5.4 | - | 0.53 |
| 2026-03-23 | CLBT | 14.83 | -5.4 | - | 0.53 |
| 2026-03-24 | CLBT | 14.21 | -5.4 | - | 0.53 |
| 2026-03-25 | CLBT | 14.15 | -5.4 | - | 0.53 |
| 2026-03-26 | CLBT | 13.77 | -5.4 | - | 0.53 |
| 2026-03-27 | CLBT | 12.94 | -5.4 | - | 0.53 |
| 2026-03-30 | CLBT | 13.23 | -5.4 | - | 0.53 |
| 2026-03-31 | CLBT | 13.79 | -5.4 | - | 0.53 |
| 2026-04-01 | CLBT | 13.89 | -5.4 | - | 0.53 |
| 2026-04-02 | CLBT | 13.99 | -5.4 | - | 0.53 |
| 2026-04-06 | CLBT | 14.10 | -5.4 | - | 0.53 |
| 2026-04-07 | CLBT | 14.15 | -5.4 | - | 0.53 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | CLBT | 0.00 | 1.39 | 4.47 |
| 2026-03-10 | CLBT | 0.00 | 1.39 | 4.47 |
| 2026-03-11 | CLBT | 0.00 | 1.39 | 4.13 |
| 2026-03-12 | CLBT | 0.00 | 1.39 | 4.13 |
| 2026-03-13 | CLBT | 0.00 | 1.39 | 4.13 |
| 2026-03-17 | CLBT | 0.00 | 1.40 | 4.13 |
| 2026-03-18 | CLBT | 0.00 | 1.40 | 4.13 |
| 2026-03-19 | CLBT | 0.00 | 1.40 | 3.96 |
| 2026-03-20 | CLBT | 0.00 | 1.40 | 3.96 |
| 2026-03-23 | CLBT | 0.00 | 1.42 | 3.96 |
| 2026-03-24 | CLBT | 0.00 | 1.42 | 3.96 |
| 2026-03-25 | CLBT | 0.00 | 1.42 | 4.09 |
| 2026-03-26 | CLBT | 0.00 | 1.42 | 4.09 |
| 2026-03-27 | CLBT | 0.00 | 1.42 | 4.09 |
| 2026-03-30 | CLBT | 0.00 | 1.43 | 4.09 |
| 2026-03-31 | CLBT | 0.00 | 1.43 | 4.09 |
| 2026-04-01 | CLBT | 0.00 | 1.43 | 4.09 |
| 2026-04-02 | CLBT | 0.00 | 1.43 | 4.09 |
| 2026-04-06 | CLBT | 0.00 | 1.42 | 4.09 |
| 2026-04-07 | CLBT | 0.00 | 1.42 | 4.09 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.09
Avg. EPS Est. Current Quarter
0.09
Avg. EPS Est. Next Quarter
0.12
Insider Transactions
Institutional Transactions
1.42
Beta
1.3
Average Sales Estimate Current Quarter
127
Average Sales Estimate Next Quarter
134
Fair Value
12.9
Quality Score
98
Growth Score
87
Sentiment Score
51
Actual DrawDown %
46.2
Max Drawdown 5-Year %
Target Price
21.67
P/E
45.44
Forward P/E
31.23
PEG
1.34
P/S
7.42
P/B
7.26
P/Free Cash Flow
22.02
EPS
0.31
Average EPS Est. Cur. Y
0.53
EPS Next Y. (Est.)
0.61
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
16.36
Relative Volume
0.47
Return on Equity vs Sector %
-37.7
Return on Equity vs Industry %
-14.5
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
◆
CLBT
Technology
$14.15
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
49.6
Range 1M
53.3%
Sup Dist
1.6%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
18.7%
EPS NY
23.1%
52W%
27%
Long-Term Value
Quality companies, undervalued
WATCH
🟢 BUY
+33.4% upside
Upside
+33.4%
Quality
98
MoS
-9%
Cellebrite DI Ltd.Sector: Technology
Industry: Software - Infrastructure
Employees: 1285
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
CLBT
Latest News
—
Caricamento notizie per CLBT…
stock quote shares CLBT – Cellebrite DI Ltd. Stock Price stock today
news today CLBT – Cellebrite DI Ltd. stock forecast ,stock prediction 2023 2024 2025
marketwatch CLBT – Cellebrite DI Ltd. yahoo finance google finance
stock history CLBT – Cellebrite DI Ltd. invest stock market
stock prices CLBT premarket after hours
ticker CLBT fair value insiders trading